The capsule polysaccharide from serogroups A, B, C, W, and Y meningococci inhibits C1q interaction with bound anti-fHbp and anti-porin A antibodies, and, consequently, the deposition of C4b and classical complement pathway (Jarvis and Vedros, 1987), as well as LOS sialylation (Vogel et al., 1997), limits C3 deposition, inhibiting the alternative pathway
Liammongkolkul, S., Kuptanon, C., Wasant, P., Vatanavicharn, N., Sawangareetrakul, P., Keeratichamroen, S., Cairns, J
So they were, they were asking for money, for funding, for like a phase three drug trial for a oral, I think it was an IL 17 blocker
Lipo and B12 shot consultations start with your goals, energy, and whether nutrient injections actually fit your situation rather than being assumed